TrialTrial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study
Trial details
- Registry ID
- NCT05629390
- Phase
- Phase 3
Drug research
Vehicle Control
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Placebo
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA StudyNCT05629390 | LianBio LLC | Phase 3 | Completed | 2023-09-15Actual |
| PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's DiseaseNCT01155362 | Celularity Incorporated | Phase 2 | Completed | 2012-02Actual |
PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease
Trial details
- Registry ID
- NCT01155362
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |